RKAGY — Stock Film
STOCK FILMSCENE 1/11RKAGY · $8.16
Stock Expert AI presents
RKAGY
RHÖN-KLINIKUM Aktiengesellschaft
~4 min film100% real numbersplain English
WHAT DOES THIS COMPANY DO?
RHÖN-KLINIKUM Aktiengesellschaft. What it actually does.

Provides in-patient hospital care for a variety of medical conditions. Offers semi-patient and outpatient medical services. Now — the numbers.

on the stock market since 2013
19K employees
$1.1B market value
Revenue last year:
$2.2B
The net profit left over:
$38.4M
Out of every $100 in sales, $2 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 2%

This is an established company with proven profits.

THE SALES TREND
Sales are moving sideways.

No real growth (4% a year).

$1.8B
2021
2022
2023
2024
$2.2B
2025
Cash on hand:
$382.5M
Total debt:
$141.7M
The cash outweighs the debt.

If every debt were paid off today, $240.9M would still be left in the vault — a solid cushion for hard times.

THE PRICE TAG
MARKET VALUE / ANNUAL PROFIT
28.4×

The market pays 28.4× for every dollar of annual profit — around what a business like this usually costs.

No analyst target is on record for this company.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 3 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

WEAK SPOTS
The stock has lost its spark0/10
Thin profit on each sale3/10
Costs eat into the margin4/10
WORTH WATCHING

Profit per Sale: The profit kept from each sale is thin.

THE FIVE-YEAR JOURNEY
Trading below its recent peak.

The stock trades below its recent peak — about 14% off the top. A pullback, not a collapse.

1
THE BRIGHT SIDE · 1/2
Strong cash, light debt

There is $382.5M in the vault; even if every debt were paid off, $240.9M would remain.

2
THE BRIGHT SIDE · 2/2
Pays a steady dividend

It pays out $0.12 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
The stock has lost its spark

The price action doesn’t yet back an upward turn. Council score: 0/10.

2
THE RISKS · 2/3
Thin profit on each sale

As the slice kept from each sale thins out, so does the profit. Council score: 3/10.

3
THE RISKS · 3/3
Costs eat into the margin

Costs swallow the gains that sales growth brings in. Council score: 4/10.

FINALE · THE GRADE
grade pending

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

One-line summary: few numbers, an untested story. Keep watching.

What would you like to do next?
Open the stock page →

Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.

This was a film — not investment advice.
Data: FMP & company filings
Sep 11, 2026 · stockexpertai.com · Stock Film